Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
205.7 EUR | -0.96% | -1.25% | -14.11% |
04-23 | SARTORIUS STEDIM BIOTECH : Barclays reaffirms its Neutral rating | ZD |
04-22 | Sartorius Stedim: in the red with brokerage comments | CF |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.11% | 21.56B | |
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 68.11B | |
+2.39% | 50.53B | |
+9.36% | 44.8B | |
+2.70% | 40.7B | |
+24.51% | 32.3B | |
+3.43% | 26.53B | |
-0.32% | 24.96B |
- Stock Market
- Equities
- DIM Stock
- News Sartorius Stedim Biotech
- Transcript : Sartorius Stedim Biotech S.A., Sartorius Aktiengesellschaft, H1 2023 Earnings Call, Jul 21, 2023